Mary Langowksi
CIK 2017441 · EVP, President U.S. Healthcare · last filed 2025-08-28
Mary Langowksi is an EVP, President U.S. Healthcare who has filed 4 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for WBA, was dated Aug 28, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) Delisted | EVP, President U.S. Healthcare | 0 | $11.98 | $0 | $0 | 4 | 2025-08-28 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-28 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Disp (D) | −494,295 | $0 | EDGAR |
| 2025-06-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Tax (F) | −40,304 | -$452.8K | EDGAR |
| 2024-11-05 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | +256,684 | $0 | EDGAR |
| 2024-06-04 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | +256,739 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.